Kininogen Cleavage Assay: Diagnostic Assistance for Kinin-Mediated Angioedema Conditions.
BACKGROUND
Angioedema without wheals (AE) is a symptom characterised by localised episodes of oedema presumably caused by kinin release from kininogen cleavage. It can result from a hereditary deficiency in C1 Inhibitor (C1Inh), but it can present with normal level of C1Inh. These forms are typically difficult to diagnose although enhanced kinin production is suspected or demonstrated in some cases.


OBJECTIVE
We wanted to investigate bradykinin overproduction in all AE condition with normal C1Inh, excluding cases with enhanced kinin catabolism, and to propose this parameter as a disease biomarker.


METHODS
We retrospectively investigated high molecular weight kininogen (HK) cleavage pattern, using gel electrophoresis and immunorevelation. Plasma samples were drawn using the same standardised procedure from blood donors or AE patients with normal C1Inh conditions, normal kinin catabolism, and without prophylaxis.


RESULTS
Circulating native HK plasma concentrations were similar in the healthy men (interquartile range: 98-175μg/mL, n = 51) and in healthy women (90-176μg/mL, n = 74), while HK cleavage was lower (p<0.001) in men (0-5%) than women (3-9%). Patients exhibited lower native HK concentration (p<10-4; 21-117μg/mL, n = 31 for men; 0-84μg/mL, n = 41 for women) and higher HK cleavage (p<10-4; 10-30% and 14-89%, respectively) than healthy donors. Pathological thresholds were set at: <72μg/mL native HK, >14.4% HK cleavage for men; <38μg/mL; native HK, >33.0% HK cleavage for women, with >98% specificity achieved for all parameters. In plasma from patients undergoing recovery two months after oestrogen/progestin combination withdrawal (n = 13) or two weeks after AE attack (n = 2), HK cleavage was not fully restored, suggesting its use as a post-attack assay.


CONCLUSIONS
As a diagnostic tool, HK cleavage can offer physicians supportive arguments for kinin production in suspected AE cases and improve patient follow-up in clinical trials or prophylactic management.
GREPI EA7408, Université Grenoble Alpes, Grenoble, France.
Rémi
R
Baroso
GREPI EA7408, Université Grenoble Alpes, Grenoble, France.|KininX SAS, Grenoble, France.
Pauline
P
Sellier
GREPI EA7408, Université Grenoble Alpes, Grenoble, France.|National Reference Center for Angioedema Grenoble, France.
Federica
F
Defendi
GREPI EA7408, Université Grenoble Alpes, Grenoble, France.|National Reference Center for Angioedema Grenoble, France.
Delphine
D
Charignon
GREPI EA7408, Université Grenoble Alpes, Grenoble, France.|KininX SAS, Grenoble, France.
Arije
A
Ghannam
GREPI EA7408, Université Grenoble Alpes, Grenoble, France.|Qalam-Antibody, La Tronche, France.
Mohammed
M
Habib
GREPI EA7408, Université Grenoble Alpes, Grenoble, France.|National Reference Center for Angioedema Grenoble, France.
Christian
C
Drouet
GREPI EA7408, Université Grenoble Alpes, Grenoble, France.
Bertrand
http://orcid.org/0000-0002-8356-0219
B
Favier
Transfus Apher Sci. 2003 Dec;29(3):215-9
14572812
N Engl J Med. 2002 Aug 22;347(8):621-2
12192030
J Clin Invest. 2015 Aug 3;125(8):3132-46
26193639
Dermatology. 2012;225(1):62-9
22922353
Acta Derm Venereol. 2016 Mar;96(3):373-6
26336842
J Exp Med. 1978 Feb 1;147(2):488-99
75240
Allergy Asthma Proc. 2012 Nov-Dec;33 Suppl 1:S145-56
23394603
J Allergy Clin Immunol. 2008 Feb;121(2):429-33
18158172
Transfus Clin Biol. 2011 Apr;18(2):224-9
21470890
Am J Obstet Gynecol. 2005 Oct;193(4):1508-12
16202747
Mol Immunol. 2010 Aug;47(13):2161-9
20580091
Lancet. 1998 Jun 6;351(9117):1693-7
9734886
J Clin Invest. 1984 Apr;73(4):954-62
6561202
Peptides. 2000 Dec;21(12):1903-40
11150653
Med Decis Making. 1984;4(2):137-50
6472062
J Allergy Clin Immunol. 2013 Oct;132(4):986-9.e1-5
23849223
Clin Chem. 1985 Mar;31(3):423-6
3971563
Dermatology. 2015;230(4):324-31
25720836
Blood. 1997 May 1;89(9):3213-8
9129025
Allergy. 2014 Dec;69(12):1659-65
25134986
Proc Natl Acad Sci U S A. 1976 Nov;73(11):4179-83
1069308
J Allergy Clin Immunol. 2016 Aug;138(2):359-66
27246526
Blood. 1997 Nov 15;90(10):3819-43
9354649
PLoS One. 2013 Aug 05;8(8):e70140
23940538
J Am Acad Dermatol. 2005 Sep;53(3):373-88; quiz 389-92
16112343
J Allergy Clin Immunol. 2015 Apr;135(4):1031-43.e6
25240785
Ann Allergy Asthma Immunol. 2014 May;112(5):413-8
24484972
Am J Hum Genet. 2006 Dec;79(6):1098-104
17186468
N Engl J Med. 2008 Sep 4;359(10):1027-36
18768946
Proc Natl Acad Sci U S A. 2015 Mar 31;112(13):4068-73
25775543
Biometrics. 1980 Mar;36(1):167-71
7370371
Allergy. 2014 May;69(5):602-16
24673465
Clin Immunol. 2013 Oct;149(1):142-5
23994767
Allergy. 2015 Sep;70(9):1103-11
26010015
J Allergy Clin Immunol. 1983 Jul;72(1):54-60
6222104
Allergy. 2010 Oct;65(10):1331-6
20384613
Thromb Haemost. 2010 Nov;104(5):886-93
20806108
J Allergy Clin Immunol. 2009 Jan;123(1):262-4
19130939
Biochemistry. 1984 Jan 17;23(2):273-9
6607744
Clin Chim Acta. 1988 May 31;174(2):121-30
3260154
Lancet. 2002 Aug 17;360(9332):535-41
12241658
Clin Exp Allergy. 2014 Dec;44(12):1503-14
24552232
Allergy. 2015 Jan;70(1):115-9
25186184
Am J Physiol Heart Circ Physiol. 2001 Jul;281(1):H275-83
11406494
Trends Mol Med. 2009 Feb;15(2):69-78
19162547